Bioavailability to drive drug delivery deals in 2013 says analyst
Demand for improved bioavailability solutions will drive drug delivery dealmaking in 2013 according to a pharmaceutical industry expert.
Demand for improved bioavailability solutions will drive drug delivery dealmaking in 2013 according to a pharmaceutical industry expert.
Aptuit says that collaboration amongst its global facilities was a key factor in bringing Lomitapide to market.